Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Injection to Prevent Post-procedural Atrial Fibrillation in Atrial Flutter Patients
NCT02002962Phase 2Unknown
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Jun 2013
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Atrial fibrillation (AFib), sponsored by E. Meshalkin National Medical Research Centre. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02002962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002962.